Figure 2.
(A) OS of 175 patients with CML based on mutation status (mutated vs. non-mutated) and (B) T315I mutation status (with T315I mutation vs. without T315I mutation). P<0.01. CML, chronic myeloid leukaemia; OS, overall survival.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.